Evidence mapPaperPMID 34307689Full record

ArticleJournal of diabetes research2021

Diabetes Management Delivery and Pregnancy Outcomes in Women with Gestational Diabetes Mellitus during the First Wave of the 2020 COVID-19 Pandemic: A Single-Reference Center Report.

Magdalena Wilk, Paulina Surowiec, Bartłomiej Matejko, Albert Wróbel, Joanna Zięba-Parkitny, Katarzyna Cyganek, Hubert Huras, Maciej T Małecki

Open access · goldAbstract read
In one paragraph

Article in Journal of diabetes research, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
2.5field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Magdalena WilkDepartment of Metabolic Diseases, Jagiellonian University Medical College, Krakow, Poland.ORCID https://orcid.org/0000-0002-4322-5838
Paulina SurowiecDepartment of Metabolic Diseases, Jagiellonian University Medical College, Krakow, Poland.ORCID https://orcid.org/0000-0002-4287-9063
Bartłomiej MatejkoDepartment of Metabolic Diseases, Jagiellonian University Medical College, Krakow, Poland.ORCID https://orcid.org/0000-0001-6938-352X
Albert WróbelStudents' Scientific Group, Department of Metabolic Diseases, Jagiellonian University Medical College, Krakow, Poland.ORCID https://orcid.org/0000-0002-4538-1498
Joanna Zięba-ParkitnyUniversity Hospital, Krakow, Poland.ORCID https://orcid.org/0000-0003-0989-7363
Katarzyna CyganekDepartment of Metabolic Diseases, Jagiellonian University Medical College, Krakow, Poland.ORCID https://orcid.org/0000-0003-2673-3512
Hubert HurasUniversity Hospital, Krakow, Poland.ORCID https://orcid.org/0000-0001-6661-6893
Maciej T MałeckiDepartment of Metabolic Diseases, Jagiellonian University Medical College, Krakow, Poland.ORCID https://orcid.org/0000-0002-4794-0820
Jagiellonian University · PLKrakow Cardiovascular Research Institute · PL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesThe COVID-19 pandemic has forced a rapid adaptation of healthcare services to secure care for many patient groups. This includes women with gestational diabetes mellitus (GDM). We evaluated the impacts of the first COVID-19 wave on parameters such as the GDM treatment, glycemic control, and pregnancy outcomes.

methodsIn this retrospective study from a reference diabetes center (Krakow, Poland), we compared patient data from two different time periods: the first wave of the COVID-19 pandemic (March 2020-June 2020) and the preceding five months (October 2019-February 2020). Data was collected from the medical records and telephone surveys.

resultsWe included 155 consecutive women (group N1 = 73 and group N2 = 82 from the COVID-19 pandemic period and non-COVID-19 period, respectively). During the COVID-19 pandemic, almost half of all GDM women (N1 = 36, 49.3%) used telemedicine as a method of contacting their diabetic specialists while this tool was not utilized in the earlier period. Moreover, these patients reported difficulties in performing blood glucose self-control more often (N1 = 20, 27.4%, vs N2 = 7, 8.5%;

conclusionIn this single-center observational study, the first wave of the COVID-19 pandemic did not seem to have a negative impact on pregnancy outcomes in GDM women, despite the difficulties in diabetes management delivery.

Indexed as

PandemicsSARS-CoV-2AdultBlood GlucoseCOVID-19Diabetes, GestationalDisease ManagementFemaleHumansInfant, NewbornPolandPregnancyPregnancy OutcomeRetrospective StudiesTelemedicineBlood Glucose

Identifiers

PMID34307689
PMCPMC8279845
OpenAlexW3179028902

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.